Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 April 2008, Vol. 111, No. 7, pp. 3863-3866.
Prepublished online as a Blood First Edition Paper on January 14, 2008; DOI 10.1182/blood-2007-09-111971.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Methods, Table, and Figures
Right arrow All Versions of this Article:
blood-2007-09-111971v1
111/7/3863    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, S.
Right arrow Articles by Skoda, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, S.
Right arrow Articles by Skoda, R. C.
Related Collections
Right arrow Neoplasia
Right arrow Oncogenes and Tumor Suppressors
Right arrow Brief Reports
Right arrow Clinical Trials and Observations
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Brief Report

Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations

Sai Li1, Robert Kralovics2, Gennaro De Libero3, Alexandre Theocharides4, Heinz Gisslinger2, and Radek C. Skoda1

1 Department of Research, Experimental Hematology, University Hospital Basel, Basel, Switzerland; 2 Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, and the Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, Austria; 3 Department of Research, Experimental Immunology and 4 Division of Hematology, University Hospital Basel, Basel, Switzerland

We studied the lineage distribution of JAK2 mutations in peripheral blood of 8 polycythemia vera (PV) patients with exon 12 mutations and in 21 PV patients with JAK2-V617F. Using a quantitative allele discrimination assay, we detected exon 12 mutations in purified granulocytes, monocytes, and platelets of 8 patients studied, but lymphoid cells showed variable involvement and the mutation was absent in T cells. Endogenous erythroid colonies grew in all patients analyzed. One patient displayed erythroid colonies homozygous for the exon 12 mutation with evidence for mitotic recombination on chromosome 9p. In some patients with exon 12 mutations or JAK2-V617F, a proportion of endogenous erythroid colonies were negative for both JAK2 mutations. One patient carried 2 independent clones: one with an exon 12 mutation and a second with JAK2-V617F. The finding of clonal heterogeneity is compatible with the hypothesis that additional clonal events are involved in the pathogenesis of PV.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
J. H. Ohyashiki, H. Hisatomi, S. Shimizu, M. Sugaya, and K. Ohyashiki
Detection of Low Allele Burden of JAK2 Exon 12 Mutations Using TA-cloning in Patients with Erythrocytosis
Jpn. J. Clin. Oncol., June 2, 2009; (2009) hyp048v1.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
S. Schnittger, U. Bacher, C. Haferlach, T. Geer, P. Muller, J. Mittermuller, P. Petrides, R. Schlag, R. Sandner, J. Selbach, et al.
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
Haematologica, March 1, 2009; 94(3): 414 - 418.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. X. Schaub, R. Jager, R. Looser, H. Hao-Shen, S. Hermouet, F. Girodon, A. Tichelli, H. Gisslinger, R. Kralovics, and R. C. Skoda
Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F
Blood, February 26, 2009; 113(9): 2022 - 2027.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
A. Theocharides, J. R. Passweg, M. Medinger, R. Looser, S. Li, H. Hao-Shen, A. S. Buser, A. Gratwohl, A. Tichelli, and R. C. Skoda
The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders
Haematologica, December 1, 2008; 93(12): 1890 - 1893.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
A. V. Jones, N. C.P. Cross, H. E. White, A. R. Green, and L. M. Scott
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis
Haematologica, October 1, 2008; 93(10): 1560 - 1564.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020